ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes

ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes

<p><strong>Objectives</strong></p> <p>The use of aspirin for the secondary prevention of cardiovascular disease (CVD) is firmly established, and the proportional reductions in heart attacks and strokes appear to be similar in people with and without diabetes. Uncertaint...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Bowman, L, Mafham, M, Stevens, W, Haynes, R, Buck, G, Collins, R, Armitage, J, ASCEND Study Collaborative Group
פורמט:	Journal article
יצא לאור:	Elsevier 2017

פריטים דומים

Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial
מאת: Parish, S, et al.
יצא לאור: (2022)

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
מאת: Emily L. Sammons, et al.
יצא לאור: (2024-11-01)

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
מאת: Sarah Parish, et al.
יצא לאור: (2023-03-01)

ASCEND-Eye: effects of aspirin on diabetic retinopathy
מאת: Sammons, E, et al.
יצא לאור: (2024)

ASCEND-Eye: effects of omega-3 fatty acids on diabetic retinopathy
מאת: Sammons, E, et al.
יצא לאור: (2023)

ASCEND-eye: rationale, design and baseline characteristics for a sub-study of the ASCEND randomized trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
מאת: Sammons, E, et al.
יצא לאור: (2023)

ASCEND-Eye: Rationale, design and baseline characteristics for a sub-study of the ASCEND randomised trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
מאת: Emily Sammons, et al.
יצא לאור: (2023-10-01)

Effects of aspirin for primary prevention in persons with diabetes mellitus
מאת: Bowman, L, et al.
יצא לאור: (2018)

Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND).
מאת: Aung, T, et al.
יצא לאור: (2016)

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
מאת: Parish, S, et al.
יצא לאור: (2023)

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
מאת: Sammons, EL, et al.
יצא לאור: (2024)

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
מאת: Sammons, EL, et al.
יצא לאור: (2024)

Effects of omega−3 fatty acid supplements on arrhythmias
מאת: Parish, S, et al.
יצא לאור: (2020)

Aspirin for primary prevention of vascular disease in people with diabetes.
מאת: Haynes, R, et al.
יצא לאור: (2009)

Thromboxane biosynthesis and future events in diabetes: the ASCEND trial
מאת: Petrucci, G, et al.
יצא לאור: (2024)

Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes
מאת: Praveen Patel, et al.
יצא לאור: (2025-02-01)

Streamlined mail-based methods for large randomised trials: lessons learnt from the ASCEND study
מאת: Mafham, MM, et al.
יצא לאור: (2019)

The ASCEND-Eye study: effect(s) of aspirin and omega-3 fatty acids on eye disease
מאת: Sammons, E
יצא לאור: (2023)

Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial
מאת: Aung, T, et al.
יצא לאור: (2017)

Effects of n-3 fatty acid supplements in diabetes mellitus
מאת: Ascend Study Collaborative Group, et al.
יצא לאור: (2018)

Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial
מאת: Rocca, B, et al.
יצא לאור: (2020)

Comparison of routinely collected data with clinical trial adjudicated direct follow-up: post-hoc analyses of serious cardiovascular events from the United Kingdom-based ASCEND randomized trial
מאת: Harper, C, et al.
יצא לאור: (2021)

Comparison of the accuracy and completeness of records of serious vascular events in routinely collected data vs clinical trial–adjudicated direct follow-up data in the UK: secondary analysis of the ascend randomized clinical trial
מאת: Harper, C, et al.
יצא לאור: (2021)

Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial.
מאת: Andrea K Viecelli, et al.
יצא לאור: (2019-01-01)

Performance of the UKPDS Outcomes Model 2 in a contemporary UK type 2 diabetes trial cohort
מאת: Keng, MJ, et al.
יצא לאור: (2021)

Comparison of effectiveness of low-dose aspirin versus omega-3 fatty acids as adjuvants to nonsurgical periodontal therapy in Type II diabetic patients with chronic periodontitis
מאת: Prathyusha Rampally, et al.
יצא לאור: (2019-01-01)

Granulation tissue enriched by aspirin and omega-3 fatty acids in healing experimental periodontal lesion
מאת: Filip Hromcik, et al.
יצא לאור: (2021-06-01)

Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.
מאת: Hartweg, J, et al.
יצא לאור: (2008)

Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.
מאת: Hartweg, J, et al.
יצא לאור: (2008)

Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia.
מאת: Eugene Han, et al.
יצא לאור: (2016-01-01)

Synergistic effects of omega-3 polyunsaturated fatty acids and aspirin in the clinical practice – a narrative review
מאת: Zajac-Grabiec Anna, et al.
יצא לאור: (2024-03-01)

Omega-3 fatty acids, insulin resistance and type 2 diabetes
מאת: Leila Azadbakht, et al.
יצא לאור: (2011-01-01)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
מאת: Price, H, et al.
יצא לאור: (2009)

Aspirin for primary prevention of cardiovascular disease in diabetes
מאת: Ying Xing, et al.
יצא לאור: (2019-07-01)

N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.
מאת: Emberson, JR, et al.
יצא לאור: (2007)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
מאת: Cull, C, et al.
יצא לאור: (2004)

Prescription omega-3 fatty acid products: considerations for patients with diabetes mellitus
מאת: Tajuddin N, et al.
יצא לאור: (2016-04-01)

Omega-3 fatty acids coordinate glucose and lipid metabolism in diabetic patients
מאת: Pasquale Mone, et al.
יצא לאור: (2022-03-01)

The relationship of dietary omega-3 fatty acid and omega-6 to omega-3 ratio intake and likelihood of type 2 diabetes in a cross-sectional study
מאת: Ebrahim Shakiba, et al.
יצא לאור: (2024-11-01)

Benefit of heparin plus aspirin vs aspirin alone in unstable angina.
מאת: Collins, R, et al.
יצא לאור: (1996)